Eastern and South-Eastern Asia vs South Africa: Proportion of the target population who received the final dose of
Eastern and South-Eastern Asia
21.0%
in 2024
South Africa
79.0%
in 2024
Eastern and South-Eastern Asia rank
26th
South Africa rank
24th
Proportion of the target population who received the final dose of over time
- Eastern and South-Eastern Asia
- South Africa
How they compare
South Africa currently reports 79.0% against 21.0% in Eastern and South-Eastern Asia, a difference of 58.0%.
That makes South Africa's figure about 3.8 times Eastern and South-Eastern Asia's.
The two have swapped places 2 times across 11 shared years of data; in 2014 it was South Africa ahead.
Eastern and South-Eastern Asia ranks 26th and South Africa ranks 24th of 35 groups.
South Africa has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Eastern and South-Eastern Asia | South Africa | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 3.7% | 55.0% | 51.3% | South Africa |
| 2020s | 8.8% | 47.0% | 38.2% | South Africa |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Eastern and South-Eastern Asia or South Africa?
- South Africa, at 79.0% against 21.0% in Eastern and South-Eastern Asia as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Eastern and South-Eastern Asia and South Africa?
- 58.0%, with South Africa ahead.
- How many years of comparable data are there for Eastern and South-Eastern Asia and South Africa?
- 11 years are reported by both, from 2014 to 2024.
- How do Eastern and South-Eastern Asia and South Africa rank globally for proportion of the target population who received the final dose of?
- Eastern and South-Eastern Asia ranks 26th and South Africa ranks 24th of 35 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.